QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 限定条件 发表日期：2021     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Liposome-paclitaxel and carboplatin combination chemoradiotherapy for patients with locally advanced esophageal squamous cell carcinoma 期刊论文 CANCER RADIOTHERAPIE, 2021, 卷号: 25 作者:  Zeng, J.;  Cui, X.;  Cheng, L.;  Chen, Y.;  Du, X. 收藏  |  浏览/下载：23/0  |  提交时间：2021/08/31 Esophageal squamous cell carcinoma  Liposome-paclitaxel  Chemoradiotherapy  Toxicities   Neoadjuvant pembrolizumab with chemotherapy for the treatment of stage IIB-IIIB resectable lung squamous cell carcinoma 期刊论文 JOURNAL OF THORACIC DISEASE, 2021, 卷号: 13 作者:  Shen, Dijian;  Wang, Jiangfeng;  Wu, Jie;  Chen, Sheng;  Li, Jianqiang 收藏  |  浏览/下载：32/0  |  提交时间：2021/05/10 Neoadjuvant chemoimmunotherapy  lung squamous cell carcinoma (LUSC)  thoracic surgery  pembrolizumab   The safety and efficacy of neoadjuvant PD-1 inhibitor with chemotherapy for locally advanced esophageal squamous cell carcinoma 期刊论文 JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 卷号: 12 作者:  Shen, Dijian;  Chen, Qixun;  Wu, Jie;  Li, Jianqiang;  Tao, Kaiyi 收藏  |  浏览/下载：42/0  |  提交时间：2021/04/26 Neoadjuvant immunotherapy  esophageal squamous cell carcinoma (ESCC)  thoracic surgery  programmed death 1 (PD-1)